John Docherty



Sort by : relevance - date
5Vote!

Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th

AURORA, Ontario, Nov. 6 /PRNewswire-FirstCall/ -- Helix BioPharma Corp. (TSX, FSE: "HBP" / Pink Sheets: HXBPF) today announced that John Docherty, president and chief operating officer, will present at Merriman Curhan Ford's 6th annual Investor Summit on November 10, 2009 at 4:00 PM at the Sofitel Hotel in New York City. Mr. Docherty will provide an overview of the Company's...

3Vote!

SFL: Raith Rovers v Dunfermline

Raith Rovers v Dunfermline John Docherty RAITH ROVERS keeper David McGurn believes the club are fitting in so well in the First Division because they are physically at their peak.The sports fitness lecturer is sure manager John McGlynn's training regime is a major factor behind the club's impressive climb into third place in the table, just two points off the top.But McGurn also...

3Vote!

Division 1: Raith Rovers v Dunfermline

Raith Rovers v Dunfermline John Docherty RAITH ROVERS keeper David McGurn believes the club are fitting in so well in the First Division because they are physically at their peak.The sports fitness lecturer is sure manager John McGlynn's training regime is a major factor behind the club's impressive climb into third place in the table, just two points off the top.But McGurn also...

3Vote!

Helix BioPharma Corp. Completes Enrollment In Its Phase II Trial Of Topical Interferon Alpha-2b In Patients With Ano-Genital Warts

... is an important milestone for Helix's Topical Interferon Alpha-2b clinical program," said John Docherty, president and COO of Helix BioPharma. "Our efforts to enhance the recruitment rate over recent months have been successful, and we now look forward to obtaining the results of this trial once all patient procedures and analyses are completed."Moving forward, based on the trial...

4Vote!

Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts

... "This is an important milestone for Helix's Topical Interferon Alpha-2b clinical program," said John Docherty, president and COO of Helix BioPharma. "Our efforts to enhance the recruitment rate over recent months have been successful, and we now look forward to obtaining the results of this trial once all patient procedures and analyses are completed."Moving forward, based on the...

3Vote!

SFL: Division One: Dunfermline 1 Dundee 1

Division One: Dunfermline 1 Dundee 1 John Docherty TONY Bullock may be 37 but the big keeper is still a class act - as Dunfermline frontman David Graham found out to his cost.Like everyone else in the 4001 crowd, Graham thought his fierce 82nd-minute drive in the was destined for the top corner of the net until the Dundee No.1 somehow got his hand to the ball.The striker described the...